Hematologic and musculoskeletal disorders stock segment: trending tickers

KROS

Keros Therapeutics, Inc. - common stock

2.01% up 0.99% 1.02

+ Biopharma, Medicine, Hematologic and musculoskeletal disorders Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1664710/000166471023000071/0001664710-23-000071-index.htm 8-K - Keros Therapeutics, Inc. (0001664710) (Filer)

+ My List

We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.